Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05887375

Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery

Conditions: Spine Surgery, Reversal of Neuromuscular Blockade, Urinary Retention Postoperative

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 118
Sponsor: University of Missouri-Columbia

Location: University Hospital Columbia Missouri

Summary

This is an active-comparator controlled study to evaluate the effect of sugammadex compared to neostigmine/glycopyrrolate for reversal of rocuronium on the incidence of urinary retention after subjects undergo elective ambulatory spine surgery.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years * ASA Physical Status I-III Exclusion Criteria: * Inability to obtain written informed consent * Allergy to medications used in the protocol * Known or suspected neuromuscular disorders * Significant renal disease with a serum creatinine ≥ 2 mg/dL * Significant liver disease * A family history of malignant hyperthermia * History of genitourinary surgery, cancer, or radiation within the last year * Currently prescribed urological medications or diuretics * BPH or symptoms of BPH (interrupted or weak urine stream or wake up to urinate more than two times per night) * History or diagnosis of urinary incontinence or urinary retention * History of PONV with use of scopolamine * Use of Foley catheter pre- or intra- operatively * Perioperative medications that influence micturition (e.g., diuretics or intraoperative anticholinergic medication use other than NMB reversal)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05887375). StuddyBuddy aggregates publicly available trial information.